Stryker Misses Q1, Cyberattack Impacts Performance
from Business News Today | 2 Min News | The Daily News Now!
Strykers Q1 earnings missed Wall Streets expectations, with softer demand for implants and orthopedic surgery gear. The companys top earner, medical surgery and neurotechnology, grew by 5% but fell short of estimates. Orthopedics performed better, increasing by 6.3%. Shares dropped 1.8% in after-hours trading following a cyberattack by an Iranian-linked group, which disrupted systems and delayed surgeries. Despite these challenges, Stryker maintains a steady full-year outlook, competing with Zimmer Biomet and Johnson & Johnson in orthopedics. Support the show: Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN: [email protected] This is an automated, high-level news summary based on public reporting. Report issues to [email protected]. View sources & latest updates: https://sources.thednn.ai/baf96cdb81500483
Embed this episode
No transcript yet.